QTc Interval and Mortality in a Population of SARS-2-COV Infected Patients.

Alessandro Vicentini , MD; Lucrezia Masiello , MD; Sabato D’Amore , MD; Enrico Baldi , MD; Stefano Ghio , MD; Simone Savastano , MD; Antonio Sanzo, MD; Angela Di Matteo , MD; Elena Maria Seminari , MD; Marco Vincenzo Lenti , MD; Matteo Bosio, MD; Barbara Petracci, MD; Laura Frigerio, MD; Anna Sabena, MD; Guido Tavazzi , MD, PhD; Luigi Oltrona Visconti, MD; Roberto Rordorf , MD; on behalf of San Matteo COVID Cardiac Injury Task Force*

[1]  L. Epstein,et al.  Effect of Chloroquine, Hydroxychloroquine, and Azithromycin on the Corrected QT Interval in Patients With SARS-CoV-2 Infection , 2020, Circulation. Arrhythmia and electrophysiology.

[2]  M. Ramakers,et al.  High incidence of venous thromboembolic events in anticoagulated severe COVID‐19 patients , 2020, Journal of Thrombosis and Haemostasis.

[3]  D. Kristoffersen,et al.  QT prolongation predicts short-term mortality independent of comorbidity , 2019, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[4]  M. Boutjdir,et al.  Interleukin-6 inhibition of hERG underlies risk for acquired long QT in cardiac and systemic inflammation , 2018, PloS one.

[5]  T. Sacchi,et al.  QT Interval Prolongation with Global T‐Wave Inversion: A Novel ECG Finding in Acute Pulmonary Embolism , 2004, Annals of noninvasive electrocardiology : the official journal of the International Society for Holter and Noninvasive Electrocardiology, Inc.